Literature DB >> 19381567

Analysis of tRNA-directed transcription antitermination in the T box system in vivo.

Tina M Henkin1.   

Abstract

Regulation of gene expression in bacteria by cis-acting RNA elements can be investigated both in vivo and in vitro. Analyses in vivo can focus on changes in mRNA transcript levels or in protein production. Systems that are regulated at the level of premature termination of transcription are best analyzed by monitoring expression of a fusion to an easily assayable reporter gene construct or by direct measurement of the terminated and readthrough transcripts. These experimental approaches are described in the context of the Bacillus subtilis T box mechanism, which responds to uncharged tRNA as the effector, and are readily adaptable to other regulatory systems that respond to other signal molecules, and other experimental systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19381567     DOI: 10.1007/978-1-59745-558-9_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Two-codon T-box riboswitch binding two tRNAs.

Authors:  Nizar Y Saad; Vassiliki Stamatopoulou; Mélanie Brayé; Denis Drainas; Constantinos Stathopoulos; Hubert Dominique Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

2.  Riboswitch (T-box)-mediated control of tRNA-dependent amidation in Clostridium acetobutylicum rationalizes gene and pathway redundancy for asparagine and asparaginyl-trnaasn synthesis.

Authors:  Nizar Y Saad; Bettina Schiel; Mélanie Brayé; John T Heap; Nigel P Minton; Peter Dürre; Hubert Dominique Becker
Journal:  J Biol Chem       Date:  2012-04-13       Impact factor: 5.157

3.  Direct modulation of T-box riboswitch-controlled transcription by protein synthesis inhibitors.

Authors:  Vassiliki Stamatopoulou; Maria Apostolidi; Shuang Li; Katerina Lamprinou; Athanasios Papakyriakou; Jinwei Zhang; Constantinos Stathopoulos
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.